• Home
  • Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.

Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.

Author List
Frankum J, Moudry P, Brough R, Hodny Z, Ashworth A, Bartek J, Lord CJ
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1189351
Publication Year
2015
PubMed ID
25883215
Publication Title
Frankum J, Moudry P, Brough R, Hodny Z, Ashworth A, Bartek J, Lord CJ. Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. Oncotarget. 2015 May 10; 6(13):10746-58.